Diversifying Isoprenoid Platforms via Atypical Carbon Substrates and Non-model Microorganisms
Isoprenoid compounds are biologically ubiquitous, and their characteristic modularity has afforded products ranging from pharmaceuticals to biofuels. Isoprenoid production has been largely successful in Escherichia coli and Saccharomyces cerevisiae with metabolic engineering of the mevalonate (MVA)...
Guardado en:
Autores principales: | David N. Carruthers, Taek Soon Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/246ecb2c251f4a3283ac4a25861fac05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Metabolic Dependency for Host Isoprenoids in the Obligate Intracellular Pathogen <named-content content-type="genus-species">Rickettsia parkeri</named-content> Underlies a Sensitivity to the Statin Class of Host-Targeted Therapeutics
por: Vida Ahyong, et al.
Publicado: (2019) -
Systems-Level Analysis of Oxygen Exposure in <italic toggle="yes">Zymomonas mobilis</italic>: Implications for Isoprenoid Production
por: Julia I. Martien, et al.
Publicado: (2019) -
Divergent Isoprenoid Biosynthesis Pathways in <italic toggle="yes">Staphylococcus</italic> Species Constitute a Drug Target for Treating Infections in Companion Animals
por: Ana M. Misic, et al.
Publicado: (2016) -
Metabolite Sequestration Enables Rapid Recovery from Fatty Acid Depletion in <named-content content-type="genus-species">Escherichia coli</named-content>
por: Christopher J. Hartline, et al.
Publicado: (2020) -
Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of HMG CoA reductase and UBIAD1
por: Rania Elsabrouty, et al.
Publicado: (2021)